...
search icon
ebs-img

Emergent Biosolutions Inc Share Price

EBS
NYQ
$8.26
-$0.13
(-1.55%)
1D
Industry: Biotechnology Sector: Health Care

Emergent Biosolutions Inc Analyst Forecast

Emergent Biosolutions Inc Share Price Chart

Emergent Biosolutions Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$434.36M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
9.0215
Volume info-icon
This is the total number of shares traded during the most recent trading day.
165.40K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
2.44
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$4.02 L
$14.06 H
$8.26

About Emergent Biosolutions Inc, Common Stock

Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationally. It operates through Commercial Products, MCM Products, and All Other Revenues segments. The company offers ACAM2000, a smallpox and mpox vaccine; Anthrax Immune Globulin Intravenous (ANTHRASIL), a polyclonal antibody therapeutic for the treatment of inhalational anthrax; Botulism Antitoxin Heptavalent (BAT), an equine plasma antitoxin for the treatment of symptomatic botulism; BioThrax, an anthrax vaccine; CYFENDUS, a vaccine for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis; Ebanga, a monoclonal antibody for the treatment of infection caused by Orthoebolavirus zairense; Raxibacumab injection, a monoclonal antibody therapeutic for the treatment and prophylaxis of inhalational anthrax due to Bacillus anthracis; TEMBEXA, an oral antiviral for the treatment of smallpox disease caused by variola virus in adult and pediatric patients; and CNJ-016, a polyclonal antibody therapeutic to address complications from smallpox vaccination. It also provides NARCAN and KLOXXADO nasal sprays for the emergency treatment of known or suspected opioid overdose. In addition, the company offers contract development and manufacturing services comprising drug substance and product manufacturing, and packaging, as well as technology transfer, process, analytical development, and suite reservation services. Emergent BioSolutions Inc. was incorporated in 1998 and is headquartered in Gaithersburg, Maryland. more

Industry: BiotechnologySector: Health Care

Emergent Biosolutions Inc Stock Returns

Time FrameEBSSectorS&P500
1-Week Return-5.94%-2.29%-0.48%
1-Month Return-24%-1.4%-2.16%
3-Month Return-27.42%0.66%-1.49%
6-Month Return5.27%11.52%3.84%
1-Year Return49.29%3.71%20.8%
3-Year Return-13.42%23.36%75.57%
5-Year Return-90.64%34.74%73.91%
10-Year Return-74.04%127.63%240.27%

Emergent Biosolutions Inc Financials

Dec '21Dec '22Dec '23Dec '24Dec '255YR TREND
Total Revenue1.77B1.12B1.05B1.04B742.90M[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":63.2,"profit":true},{"date":"2023-12-31","value":59.16,"profit":true},{"date":"2024-12-31","value":58.84,"profit":true},{"date":"2025-12-31","value":41.89,"profit":true}]
Cost of Revenue980.40M693.70M689.30M668.20M392.30M[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":70.76,"profit":true},{"date":"2023-12-31","value":70.31,"profit":true},{"date":"2024-12-31","value":68.16,"profit":true},{"date":"2025-12-31","value":40.01,"profit":true}]
Gross Profit793.20M427.20M360.00M375.40M350.60M[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":53.86,"profit":true},{"date":"2023-12-31","value":45.39,"profit":true},{"date":"2024-12-31","value":47.33,"profit":true},{"date":"2025-12-31","value":44.2,"profit":true}]
Gross Margin44.72%38.11%34.31%35.97%47.19%[{"date":"2021-12-31","value":94.76,"profit":true},{"date":"2022-12-31","value":80.76,"profit":true},{"date":"2023-12-31","value":72.7,"profit":true},{"date":"2024-12-31","value":76.22,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Operating Expenses451.80M593.20M1.09B484.10M240.40M[{"date":"2021-12-31","value":41.59,"profit":true},{"date":"2022-12-31","value":54.6,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":44.56,"profit":true},{"date":"2025-12-31","value":22.13,"profit":true}]
Operating Income341.40M(166.00M)(726.40M)(108.70M)110.20M[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-48.62,"profit":false},{"date":"2023-12-31","value":-212.77,"profit":false},{"date":"2024-12-31","value":-31.84,"profit":false},{"date":"2025-12-31","value":32.28,"profit":true}]
Total Non-Operating Income/Expense(72.70M)(93.00M)(83.80M)(105.20M)(86.70M)[{"date":"2021-12-31","value":-7270000000,"profit":false},{"date":"2022-12-31","value":-9300000000,"profit":false},{"date":"2023-12-31","value":-8380000000,"profit":false},{"date":"2024-12-31","value":-10520000000,"profit":false},{"date":"2025-12-31","value":-8670000000,"profit":false}]
Pre-Tax Income303.20M(221.70M)(731.20M)(142.90M)82.80M[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-73.12,"profit":false},{"date":"2023-12-31","value":-241.16,"profit":false},{"date":"2024-12-31","value":-47.13,"profit":false},{"date":"2025-12-31","value":27.31,"profit":true}]
Income Taxes83.70M2.10M29.30M47.70M30.20M[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":2.51,"profit":true},{"date":"2023-12-31","value":35.01,"profit":true},{"date":"2024-12-31","value":56.99,"profit":true},{"date":"2025-12-31","value":36.08,"profit":true}]
Income After Taxes219.50M(223.80M)(760.50M)(190.60M)52.60M[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-101.96,"profit":false},{"date":"2023-12-31","value":-346.47,"profit":false},{"date":"2024-12-31","value":-86.83,"profit":false},{"date":"2025-12-31","value":23.96,"profit":true}]
Income From Continuous Operations230.90M(223.80M)(790.20M)(190.60M)52.60M[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-96.93,"profit":false},{"date":"2023-12-31","value":-342.23,"profit":false},{"date":"2024-12-31","value":-82.55,"profit":false},{"date":"2025-12-31","value":22.78,"profit":true}]
Income From Discontinued Operations-----[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Net Income219.50M(223.80M)(760.50M)(190.60M)52.60M[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-101.96,"profit":false},{"date":"2023-12-31","value":-346.47,"profit":false},{"date":"2024-12-31","value":-86.83,"profit":false},{"date":"2025-12-31","value":23.96,"profit":true}]
EPS (Diluted)6.00(2.26)(5.54)(0.94)1.50[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-37.67,"profit":false},{"date":"2023-12-31","value":-92.33,"profit":false},{"date":"2024-12-31","value":-15.63,"profit":false},{"date":"2025-12-31","value":25,"profit":true}]

Emergent Biosolutions Inc Ratios

Emergent Biosolutions Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

EBS
Cash Ratio 1.55
Current Ratio 5.01
Quick Ratio 2.41

Emergent Biosolutions Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

EBS
ROA (LTM) 5.34%
ROE (LTM) 10.46%

Emergent Biosolutions Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

EBS
Debt Ratio Lower is generally better. Negative is bad. 0.60
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.40

Emergent Biosolutions Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

EBS
Trailing PE 9.02
Forward PE 2.08
P/S (TTM) 0.59
P/B 0.83
Price/FCF 6
EV/R 1.13
EV/Ebitda 3.36
PEG 0.38

FAQs

What is Emergent Biosolutions Inc share price today?

Emergent Biosolutions Inc (EBS) share price today is $8.26

Can Indians buy Emergent Biosolutions Inc shares?

Yes, Indians can buy shares of Emergent Biosolutions Inc (EBS) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in EBS stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Emergent Biosolutions Inc be purchased?

Yes, you can purchase fractional shares of Emergent Biosolutions Inc (EBS) via the Vested app. You can start investing in Emergent Biosolutions Inc (EBS) with a minimum investment of $1.

How to invest in Emergent Biosolutions Inc shares from India?

You can invest in shares of Emergent Biosolutions Inc (EBS) via Vested in three simple steps:

  • Click on Sign Up or Invest in EBS stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Emergent Biosolutions Inc shares
What is Emergent Biosolutions Inc 52-week high and low stock price?

The 52-week high price of Emergent Biosolutions Inc (EBS) is $14.06. The 52-week low price of Emergent Biosolutions Inc (EBS) is $4.02.

What is Emergent Biosolutions Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Emergent Biosolutions Inc (EBS) is 9.0215

What is Emergent Biosolutions Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Emergent Biosolutions Inc (EBS) is 0.83

What is Emergent Biosolutions Inc dividend yield?

The dividend yield of Emergent Biosolutions Inc (EBS) is 0.00%

What is the Market Cap of Emergent Biosolutions Inc?

The market capitalization of Emergent Biosolutions Inc (EBS) is $434.36M

What is Emergent Biosolutions Inc's stock symbol?

The stock symbol (or ticker) of Emergent Biosolutions Inc is EBS

How Can Investors Use Emergent Biosolutions Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Emergent Biosolutions Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Emergent Biosolutions Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Emergent Biosolutions Inc shares for Indian investors?

When investing in Emergent Biosolutions Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Emergent Biosolutions Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Emergent Biosolutions Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Emergent Biosolutions Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Emergent Biosolutions Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top